Chris@NNW, Author at NetworkNewsWire

TuesdayMar 19, 2019 11:30 am

Origin House (CSE: OH) (OTCQX: ORHOF) Attends 31st Annual ROTH Conference

Origin House (CSE: OH) (OTCQX: ORHOF) is a cannabis products and brands company operating across key markets in the U.S. and Canada. The company’s foundation is in California where it delivers over 130 branded cannabis products to the majority of licensed dispensaries. Origin House’s brand development platform provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke. For more information, visit the company's website at www.originhouse.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content…

TuesdayMar 19, 2019 11:30 am

Organovo Holdings Inc. (NASDAQ: ONVO) Attends 31st Annual ROTH Conference

Organovo Holdings (NASDAQ: ONVO) is a biotech platform company that has developed a leadership position with its revolutionary ability to 3D bioprint tissues with human functionality. The company is pursuing multiple IND-track programs to develop its NovoTissues to address serious unmet medical needs in adult and pediatric populations, initially focusing on liver disease and the company expects to file its first IND in 2020. To support its plan to initiate multiple IND-track programs, the company is providing access to its ExVive in vitro tissue disease modeling platform to facilitate high value drug discovery and development collaborations. For more information, visit…

TuesdayMar 19, 2019 11:30 am

ORBCOMM Inc. (NASDAQ: ORBC) Attends 31st Annual ROTH Conference

ORBCOMM (NASDAQ: ORBC) is a global leader and innovator in the industrial Internet of Things, providing solutions that connect businesses to their assets to deliver increased visibility and operational efficiency. The company offers a broad set of asset monitoring and control solutions, including seamless satellite and cellular connectivity, unique hardware and powerful applications, all backed by end-to-end customer support, from installation to deployment to customer care. ORBCOMM has a diverse customer base including premier OEMs, solutions customers and channel partners spanning transportation, supply chain, warehousing and inventory, heavy equipment, maritime, natural resources, and government. For more information, visit the company's…

TuesdayMar 19, 2019 11:30 am

Oragenics Inc. (NYSE American: OGEN) Attends 31st Annual ROTH Conference

Oragenics (NYSE American: OGEN) is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus. For more information, visit the company's website at www.oragenics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

TuesdayMar 19, 2019 11:30 am

OptimizeRx Corp. (NASDAQ: OPRX) Attends 31st Annual ROTH Conference

OptimizeRx (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with healthcare providers right within their workflow. The cloud-based solution supports patient adherence to medications with real-time access to financial assistance, prior authorization, education and critical clinical information. The company’s mobile messaging platform also supports direct, real-time communication to patients for improved medication adherence, affordability, and healthcare outcomes. For more information, visit the company's website…

TuesdayMar 19, 2019 11:30 am

OpGen Inc. (NASDAQ: OPGN) Attends 31st Annual ROTH Conference

OpGen (NASDAQ: OPGN) is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital, and network-wide infection treatment and prevention. The Acuitas Lighthouse Software (RUO) is the first cloud-based software to predict antibiotic resistance, track antimicrobial resistance, and determine bacterial strain relatedness in healthcare settings using bacterial genetic data. The Acuitas AMR Gene Panel (RUO) is the most comprehensive, rapid PCR test for detecting five pathogens and 47 resistance genes which cover nine antibiotic classes. OpGen’s solutions will provide the power to prescribe empiric therapy with precision. For more information, visit the company's website at…

TuesdayMar 19, 2019 11:30 am

Clearfield Inc. (NASDAQ: CLFD) Attends 31st Annual ROTH Conference

Clearfield (NASDAQ: CLFD) designs, manufactures and distributes fiber optic management, protection and delivery products for communications networks. The company’s “fiber to anywhere” platform serves the unique requirements of leading incumbent local exchange carriers (traditional carriers), competitive local exchange carriers (alternative carriers), and MSO/cable TV companies, while also catering to the broadband needs of the utility/municipality, enterprise, data center and military markets. Headquartered in Minneapolis, Minnesota, Clearfield deploys more than a million fiber ports each year. For more information, visit the company's website at www.SeeClearfield.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…

TuesdayMar 19, 2019 11:30 am

Clarus Corp. (NASDAQ: CLAR) Attends 31st Annual ROTH Conference

Clarus (NASDAQ: CLAR) is focused on the outdoor and consumer industries, where it seeks opportunities to acquire and grow businesses that can generate attractive shareholder returns. The company has substantial net operating tax loss carryforwards which it is seeking to redeploy to maximize shareholder value. Clarus’ primary business is as a leading developer, manufacturer and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport categories. The company’s products are principally sold under the Black Diamond®, Sierra® and PIEPS® brand names through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and…

TuesdayMar 19, 2019 11:30 am

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Attends 31st Annual ROTH Conference

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For…

TuesdayMar 19, 2019 11:30 am

CohBar Inc. (NASDAQ: CWBR) Attends 31st Annual ROTH Conference

CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company focused on the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. MBTs originate from the discovery by CohBar’s founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar’s efforts focus on the development of these mitochondrial-derived peptides (MDPs) into clinically relevant MBTs that offer the potential to address a broad range of age-related diseases with underlying metabolic dysfunction. For more information, visit the company's website at www.cohbar.com.…